Main Menu

Our Work

Purdue Pharma v. Alvogen Pine Brook

In Purdue Pharma v. Alvogen Pine Brook, provided expert testimony on behalf of plaintiff to assess the commercial success of a prescription drug in a patent infringement litigation related to certain Abbreviated New Drug Applications (ANDAs) filed by the defendant. Expert written and deposition testimony was in the US District Court for the District of Delaware. The matter settled on the eve of trial. 

Jump to Page

We use cookies to optimize the performance of this site and give you the best user experience. By clicking "Accept," you agree to our use of cookies.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.